| Primary |
| Atrial Fibrillation |
50.0% |
| Deep Vein Thrombosis |
50.0% |
|
| Compartment Syndrome |
20.0% |
| International Normalised Ratio Increased |
20.0% |
| Post Procedural Complication |
20.0% |
| Spontaneous Haematoma |
20.0% |
| Synovial Sarcoma Metastatic |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
31.1% |
| Urinary Tract Infection |
10.1% |
| Atrial Fibrillation |
9.2% |
| Deep Vein Thrombosis |
9.2% |
| Plasma Cell Myeloma |
5.9% |
| Pulmonary Embolism |
5.0% |
| Hypertension |
4.2% |
| Thrombosis |
3.4% |
| Thrombosis Prophylaxis |
3.4% |
| Cardiac Failure Congestive |
2.5% |
| Infection |
2.5% |
| Anticoagulant Therapy |
1.7% |
| Arrhythmia |
1.7% |
| Depression |
1.7% |
| Gout |
1.7% |
| Lupus Nephritis |
1.7% |
| Morphoea |
1.7% |
| Pain |
1.7% |
| Blood Cholesterol Increased |
0.8% |
| Prostate Cancer |
0.8% |
|
| International Normalised Ratio Increased |
25.6% |
| Toxicity To Various Agents |
11.6% |
| Somnolence |
7.0% |
| White Blood Cell Count Increased |
7.0% |
| Dyspnoea |
4.7% |
| Prothrombin Time Prolonged |
4.7% |
| Swelling Face |
4.7% |
| Vomiting |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Complex Partial Seizures |
2.3% |
| Death |
2.3% |
| Deep Vein Thrombosis |
2.3% |
| Dizziness |
2.3% |
| Exposure During Pregnancy |
2.3% |
| Exposure Via Ingestion |
2.3% |
| Gastrointestinal Haemorrhage |
2.3% |
| Grand Mal Convulsion |
2.3% |
| Haemorrhage Subcutaneous |
2.3% |
| Heparin-induced Thrombocytopenia |
2.3% |
| Hyponatraemia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.5% |
| Plasma Cell Myeloma |
17.1% |
| Lupus Nephritis |
6.9% |
| Atrial Fibrillation |
4.9% |
| Hypertension |
4.9% |
| Pulmonary Arterial Hypertension |
3.7% |
| Depression |
3.3% |
| Chronic Lymphocytic Leukaemia |
2.8% |
| Tonsillitis |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Ill-defined Disorder |
2.4% |
| Multiple Sclerosis |
2.4% |
| Osteoporosis |
2.4% |
| Prostate Cancer |
2.4% |
| Age-related Macular Degeneration |
2.0% |
| Chronic Myeloid Leukaemia |
2.0% |
| Multiple Myeloma |
2.0% |
| Neuralgia |
2.0% |
| Pulmonary Hypertension |
2.0% |
|
| Vomiting |
12.3% |
| Pneumonia |
7.9% |
| Weight Decreased |
7.0% |
| White Blood Cell Count Decreased |
7.0% |
| Dyspnoea |
6.1% |
| Renal Failure Acute |
6.1% |
| Urinary Tract Infection |
6.1% |
| Hypomagnesaemia |
5.3% |
| Hypertension |
4.4% |
| Infection |
4.4% |
| Somnolence |
4.4% |
| Death |
3.5% |
| Herpes Zoster |
3.5% |
| International Normalised Ratio Increased |
3.5% |
| Pancytopenia |
3.5% |
| Rash |
3.5% |
| Thrombosis |
3.5% |
| Device Related Infection |
2.6% |
| Drug Ineffective |
2.6% |
| International Normalised Ratio Decreased |
2.6% |
|
